Industry Focus Transcripts

The deal creates a massive enterprise that will boast 140,000 employees, $16 billion of annual revenue, and a global scale that overshadows its closest competitors by a wide margin.

We run through a framework for analyzing companies, and we put Facebook through the wringer. Is it a buy?

It was a mixed bag for the nation's biggest banks last quarter.

The 2017 North American International Auto Show just ended, and there were big takeaways for consumers and investors alike.

A system that could revolutionize gene research and a first-in-class cancer therapy could be two of healthcare's biggest advances this year. Plus, UnitedHealth's earnings review, and a preview of Johnson & Johnson's earnings.

Women have been the driving force behind the rise of activewear and athleisure apparel, and there are few signs of slowing down.

We run through a few different tips to make your resolutions easier to hit in 2017 and talk about why we're focusing on doing more stock research, checking out credit cards, and changing our online passwords.

We chat with Daniel Kline, our "boots on the ground" correspondent at the Consumer Electronics Show to see what big tech trends were showcased last week in Las Vegas.

How to build a profit-friendly stock watch list. Plus, Trump’s tough talk on drug costs and why it’s so important to pay off your credit card debt ASAP.

We’re just a few days into OPEC’s production cut, and American oil companies and investors are already responding -- here's what you need to know.

U.S. oil production has bottomed out and is on the upswing -- here’s what you need to know to position your portfolio the right way.

Approximately half of Americans set goals for themselves at the beginning of each year.

Our cast discuss their financial New Year's Resolutions, and check the scoreboard on 12 predictions Jordan Wathen made for BDCs in 2016.

Big players are starting to make big moves as the energy markets gain some certainty -- here's what you need to know.

The healthcare sector had a rough time in 2016. This year, we hope it can make some changes that’ll turn its luck around.

Two analysts examine companies that benefit from the 21st Century Cures Act and also discuss top healthcare stocks to buy in 2017.

We look ahead to the new year and make a few predictions about wearables, M&A, and where big tech companies will be focusing their resources.

We look back at the impressive slate of movie releases from last year and what film-loving investors can expect in 2017.

From the perennial No. 3 fast food chain to a recovering soda company, two Fools pick their favorite stocks of the year that bucked expectations.

Need a last-minute present? Or maybe you know someone who could use a little book learning? Check out the Motley Fool’s book list!